FINWIRES · TerminalLIVE
FINWIRES

Avalo Therapeutics Insider Sold Shares Worth $1,513,673, According to a Recent SEC Filing

By

Paul Varki, Chief Legal Officer, on May 06, 2026, sold 75,063 shares in Avalo Therapeutics (AVTX) for $1,513,673. Following the Form 4 filing with the SEC, Varki has control over a total of 3,634 common shares of the company, with 3,634 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1534120/000167789626000004/xslF345X05/form4-05072026_080504.xml

Related Articles

Insider Trading

Schwab Charles Insider Sold Shares Worth $20,058,463, According to a Recent SEC Filing

Charles R. Schwab, Director, Co-Chairman, on May 04, 2026, sold 218,600 shares in Schwab Charles (SCHW) for $20,058,463. Following the Form 4 filing with the SEC, Schwab has control over a total of 95,323,231 common shares of the company, with 95,323,231 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/316709/000092373826000020/xslF345X05/wk-form4_1778103666.xml

$SCHW
Insider Trading

Zoom Communications Insider Sold Shares Worth $2,599,495, According to a Recent SEC Filing

Eric S. Yuan, Director, Chief Executive Officer, on May 04, 2026, sold 24,200 shares in Zoom Communications (ZM) for $2,599,495.SEC Filing:https://www.sec.gov/Archives/edgar/data/1585521/000158552126000064/xslF345X05/wk-form4_1778102851.xml

$ZM
Insider Trading

Ouster Insider Sold Shares Worth $1,040,690, According to a Recent SEC Filing

Mark Frichtl, Chief Technology Officer, on May 04, 2026, sold 34,600 shares in Ouster (OUST) for $1,040,690. Following the Form 4 filing with the SEC, Frichtl has control over a total of 712,297 common shares of the company, with 712,297 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816581/000119312526209397/xslF345X05/ownership.xml

$OUST